Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Preliminary Estimated Unaudited Full Year 2018 Results Conference Call on January 28, 2019 WEST PALM BEACH, Fla., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation...
-
WEST PALM BEACH, Fla., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, announced today that it had reached...
-
WEST PALM BEACH, Fla., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, announced today that Rakesh Sachdev,...
-
WEST PALM BEACH, Fla., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, announced today that Rakesh Sachdev,...
-
Net sales from continuing operations increased 2% on a reported basis to $489 million; growth of 3% on an organic basisGAAP diluted loss per share from continuing operations of $0.02; adjusted...
-
WEST PALM BEACH, Fla., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform") announced today that it intends to release its 2018 third quarter financial...
-
Net sales increased 9% on a reported basis to $1.02 billion; growth of 7% on an organic basisGAAP diluted earnings per share of $0.04; adjusted earnings per share increased 30% to $0.26Reported net...
-
WEST PALM BEACH, Fla, July 26, 2018 (GLOBE NEWSWIRE) -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform") announced today that it intends to release its 2018 second quarter financial...
-
Platform to change its name to Element Solutions Inc. at closing of the Arysta transactionElement Solutions Inc.’s annualized adjusted EBITDA excluding Arysta expected between $450 million to $470...
-
Platform has signed a definitive agreement to sell Arysta LifeScience Inc. to UPL Corporation Ltd. for $4.2 billion in cash, subject to customary closing adjustmentsClosing expected in late 2018 or...